Gestational Diabetes Symptoms and Treatment After the 24th Week of Pregnancy

Gestational Diabetes Symptoms and Treatment After the 24th Week of Pregnancy, humayun hospital chennai
Dr. Navaneeth P S
Doctor
๐Ÿ“… Published: October 13, 2026
๐Ÿ”„ Updated: October 13, 2026
โœ… Medically Verified
โฑ 14 min read

Gestational Diabetes Symptoms and Treatment After the 24th Week of Pregnancy

๐Ÿ’ก
Key Takeaways
The most important points from this article
โœ“

Gestational diabetes mellitus (GDM) is high blood sugar that develops during pregnancy, typically appearing between 24 and 28 weeks, and affects approximately 1 in 8 pregnancies worldwide and an estimated 10 to 15% of pregnant women in India.

โœ“

Most women with gestational diabetes have no obvious symptoms. The diagnosis is made through routine screening with an oral glucose tolerance test (OGTT) between 24 and 28 weeks of gestation.

โœ“

Uncontrolled GDM increases the risk of a large baby (macrosomia), birth complications, caesarean section, preterm birth, preeclampsia, and neonatal hypoglycaemia. With good management, most women deliver healthy babies.

โœ“

Lifestyle behaviour change, including medical nutrition therapy (MNT) and regular physical activity, is the essential first-line treatment and is sufficient to control blood sugar for many women with GDM.

โœ“

Insulin is the first-line pharmacological treatment for gestational diabetes when diet and exercise alone are insufficient. The ADA Standards of Care 2024 recommends insulin as the preferred medication because it does not cross the placenta and has a long

โœ“

At Humayun Hospital, T Nagar, Chennai, Dr. Asma Humayun provides specialist obstetric care for women with gestational diabetes, including early screening for high-risk women, personalised management plans, and close fetal monitoring throughout the third t

The routine glucose screening between 24 and 28 weeks of pregnancy is the one appointment most pregnant women know about but many have not thought deeply about. A blood test. A sugary drink. A wait. And then, for approximately 1 in 8 women, a result that changes the management of the rest of the pregnancy.

Gestational diabetes is high blood sugar during pregnancy. It is common, it is manageable, and with appropriate treatment, the large majority of women with GDM deliver healthy babies without complications. But it is also a condition that carries real risks when blood sugar is not kept within target range in the third trimester, and understanding those risks, the symptoms that may or may not appear, and the treatment that effectively controls them is the most important knowledge a woman newly diagnosed after week 24 can have.

What Is Gestational Diabetes?

Gestational diabetes mellitus is a type of diabetes that develops exclusively during pregnancy. It occurs when the body cannot produce enough insulin to meet the dramatically increased demands of pregnancy, resulting in elevated blood glucose levels.

Pregnancy hormones produced by the placenta, including human placental lactogen, progesterone, and cortisol, progressively increase insulin resistance as the pregnancy advances. This is a normal physiological process designed to ensure the fetus has an adequate glucose supply. In most women, the pancreas compensates by producing more insulin to overcome this resistance. In women who develop GDM, the compensatory response is insufficient and blood glucose rises above the normal range.

GDM usually appears during the middle of pregnancy, between 24 and 28 weeks, when placental hormone production is at a level sufficient to overwhelm compensatory capacity in susceptible women. It differs from pre-gestational diabetes (type 1 or type 2 diabetes present before pregnancy) in that it develops specifically in the context of pregnancy hormones and in the large majority of cases resolves after delivery.

India carries a particularly high GDM burden. The estimated prevalence of gestational diabetes in India ranges from 10 to 15% of all pregnancies, significantly higher than the global average, driven by the genetic predisposition of South Asians to insulin resistance at lower body weight thresholds, dietary patterns, and the rapidly rising rate of overweight and obesity in urban Indian women of reproductive age.

Gestational Diabetes Symptoms: What Women Actually Experience

This is the most important clinical fact about gestational diabetes for pregnant women: most have no symptoms at all.

There are usually no obvious warning signs of gestational diabetes. Symptoms are mild and often go unnoticed until the pregnancy care provider tests for gestational diabetes. The condition is identified by screening, not by symptoms the woman reports.

When symptoms do occur, they include:

  • Increased thirst (polydipsia) that seems disproportionate to the amount drunk

  • More frequent urination than is typical for the stage of pregnancy

  • Unusual fatigue that goes beyond normal pregnancy tiredness

  • Blurred vision

  • Increased hunger that is not satisfied by normal meals

The difficulty is that several of these symptoms overlap with the ordinary experiences of late pregnancy: thirst and frequent urination are common from the growing uterus pressing on the bladder; fatigue is near-universal in the third trimester; hunger increases as fetal demands rise. This overlap is precisely why symptoms alone are not a reliable indicator of GDM. Only the OGTT gives a reliable diagnosis.

This makes attendance at the 24 to 28-week OGTT screening appointment one of the most important actions a pregnant woman can take for her health and her baby's health, regardless of whether she has any symptoms.

Who Is Screened and How Is GDM Diagnosed?

Universal screening for all pregnant women is recommended by both the ADA 2024 Standards of Care and NICE 2022 guidelines between 24 and 28 weeks of gestation, using a 75 gram oral glucose tolerance test (OGTT).

High-risk women (those with previous GDM, first-degree family history of diabetes, BMI above 25, South Asian ethnicity, PCOS, or previous macrosomic baby) are offered earlier screening in the first trimester alongside the standard 24 to 28-week screen.

The 75 gram OGTT involves:

  • Fasting from midnight before the test

  • A fasting blood glucose measurement

  • Drinking 75 grams of glucose dissolved in water

  • Blood glucose measurements at one hour and two hours

GDM is diagnosed when any one of the following thresholds is met:

MeasurementDiagnostic Threshold
Fasting glucose5.1 mmol/L (92 mg/dL) or above
1-hour glucose10.0 mmol/L (180 mg/dL) or above
2-hour glucose8.5 mmol/L (153 mg/dL) or above

These International Association of Diabetes in Pregnancy Study Groups (IADPSG) criteria are the most widely adopted internationally and are endorsed by WHO and the ADA.

Why Managing Blood Sugar After Week 24 Matters

The specific risks of GDM depend on when in pregnancy blood sugar is elevated and how well it is controlled.

Hyperglycemia later in pregnancy, after 24 weeks, primarily results in fetal overgrowth (macrosomia) and related complications, in contrast to early pregnancy hyperglycemia which is associated with an increased risk of congenital malformations.

When GDM is uncontrolled in the third trimester, the fetal pancreas responds to the high glucose crossing the placenta by producing more insulin, which acts as a growth hormone. The result is a disproportionately large baby, particularly with excess fat around the shoulders and abdomen.

The complications of poorly controlled GDM after week 24 include:

For the baby:

  • Macrosomia (large baby): a baby above 4 kg is significantly more common with uncontrolled GDM

  • Birth injury from shoulder dystocia during delivery of a large baby

  • Neonatal hypoglycaemia after birth when the baby's own insulin levels remain high after the glucose supply is cut off at delivery

  • Respiratory distress syndrome, particularly in babies delivered early

  • Prematurity from medically indicated early delivery

  • Elevated risk of developing obesity and type 2 diabetes later in childhood and adulthood

For the mother:

  • Preeclampsia: GDM significantly elevates the risk of developing high blood pressure with protein in the urine during pregnancy

  • Caesarean section from fetal macrosomia or failed labour progress

  • Polyhydramnios (excess amniotic fluid) from fetal urination in response to high blood glucose

  • Increased risk of developing type 2 diabetes within 5 to 10 years after delivery

Gestational diabetes is not just a pregnancy concern. It is a metabolic and cardiovascular warning sign. Women who have GDM have a significantly elevated lifetime risk of type 2 diabetes and require ongoing glucose monitoring and lifestyle intervention even after the pregnancy resolves.

Gestational Diabetes Treatment: First-Line Lifestyle Approaches

Lifestyle behaviour change is an essential component of management of gestational diabetes mellitus and may suffice as treatment for many individuals. For approximately 70 to 80% of women with GDM, blood sugar control is achievable through diet and exercise alone without medication.

RUA Assistant
Your Medical Assistant
Get expert guidance from leading medical specialists.

Medical Nutrition Therapy (MNT)

Medical nutrition therapy for GDM is not a starvation diet. It is a structured approach to carbohydrate distribution that prevents blood sugar spikes while maintaining adequate nutrition for both mother and baby.

Core principles of GDM dietary management:

Carbohydrate distribution: Rather than eliminating carbohydrates, the total daily carbohydrate intake is spread evenly across three meals and two to three snacks. Large carbohydrate loads at one meal produce sharp blood glucose spikes. Smaller, more frequent carbohydrate portions produce a flatter, more manageable glucose response.

Carbohydrate quality: Low glycaemic index (GI) carbohydrates that release glucose slowly are preferred over high-GI foods that cause rapid blood sugar rises. Practical choices for Indian women:

  • Preferred: millets (ragi, jowar, bajra), brown rice (in smaller portions), whole wheat chapati, dal, legumes, vegetables

  • Limit: white rice in large portions, maida-based products, sweetened beverages, fruit juice, refined sugars and sweets

  • Breakfast is particularly important: the hormonal environment of the morning makes blood sugar rises after breakfast larger than at other meals. A low-carbohydrate breakfast (eggs, paneer, nuts, vegetables) rather than a high-carbohydrate one (idli, dosa, paratha with large portions) is often the single most impactful dietary change for GDM control.

Protein and fat: Including adequate protein and healthy fat at each meal slows gastric emptying and blunts the blood glucose response to carbohydrates consumed in the same meal.

Fruits: Most fruits raise blood sugar and should be consumed in small portions as part of a mixed meal rather than as standalone snacks. Prefer lower-GI fruits such as guava and pomelo over higher-GI options like watermelon and mango.

Avoiding sweet and sugary items: Sweet drinks, sugary chai, fruit juices, mithai, biscuits, and sweetened dairy products should be avoided throughout the GDM management period.

Physical Activity

Regular physical activity reduces insulin resistance and helps the body use glucose more effectively. A brisk walk 10 minutes after each meal is enough to lower the spike in glucose after eating. This simple intervention, immediately accessible to almost all pregnant women without equipment or a gym, is one of the most effective tools for post-meal blood glucose management in GDM.

ADA 2024 GDM guidelines recommend:

  • At least 150 minutes of moderate-intensity physical activity per week

  • Brisk walking, swimming, and prenatal yoga are safe and effective choices

  • Post-meal movement is specifically beneficial for blunting post-prandial glucose spikes

  • Avoid supine exercise after the first trimester and any activity with significant falling or contact risk

Women who were sedentary before pregnancy should start gradually and increase over two to three weeks rather than beginning intensive exercise immediately.

Blood Glucose Monitoring

Self-monitoring of blood glucose is central to GDM management. Women test their own blood glucose at prescribed times and use the results to guide dietary choices and to inform whether medication is needed.

Standard monitoring targets for GDM after meals (postprandial):

  • Fasting (before breakfast): below 5.3 mmol/L (95 mg/dL)

  • One hour after meals: below 7.8 mmol/L (140 mg/dL)

  • Two hours after meals: below 6.7 mmol/L (120 mg/dL)

These targets are based on the Fifth International Workshop-Conference on Gestational Diabetes Mellitus and are endorsed by ADA 2024. Values consistently above these targets on multiple days indicate that additional treatment (medication) is needed.

Continuous glucose monitors (CGMs) are an emerging option in GDM management. A 2024 to 2025 randomised controlled trial is actively evaluating CGM versus standard OGTT-based monitoring in GDM, with results expected to inform future guideline updates.

When Medication Is Needed: Insulin and Metformin

When dietary modification and exercise do not keep blood glucose within target ranges, medication is added. The decision is based on glucose diary readings showing persistent values above target.

Insulin: The First-Line Pharmacological Treatment

Insulin is the first-line agent recommended for the treatment of GDM in the U.S. and the ADA 2024 Standards of Care specifically recommends insulin as the preferred medication because it does not cross the placenta and has a long-established safety record. This is the most important point for patients: insulin does not harm the baby.

The type and dose of insulin is individualised based on the glucose pattern seen in the monitoring diary:

  • Fasting hyperglycaemia (high blood sugar before breakfast): typically treated with intermediate-acting or long-acting basal insulin at bedtime
  • Post-meal hyperglycaemia: typically treated with rapid-acting insulin at the relevant meal
  • Combined fasting and post-meal hyperglycaemia: basal-bolus regimen

Insulin requirements in pregnancy are not fixed. They typically increase with gestational age as placental hormone levels rise, particularly after 32 weeks, and then drop dramatically after delivery when the placenta is removed.

Women are taught to inject insulin themselves using a fine-gauge pen needle. The technique is simple and most women become confident within a few days.

Metformin

Metformin is an oral medication that reduces insulin resistance and is used in some centres as an alternative to or alongside insulin for GDM when insulin is declined or poorly tolerated. It does cross the placenta, but extensive data from large randomised trials including the MiG trial have not shown harm to the baby at standard GDM doses.

The ADA 2024 Standards of Care notes that while metformin may be used, there is growing evidence of potential long-term effects on the child from placental transfer, and insulin remains preferred as first-line. In India, metformin is commonly used in GDM management by many centres, and the decision is made in discussion between the patient and her obstetrician.

Fetal Monitoring in the Third Trimester With GDM

Close fetal monitoring is a fundamental component of GDM management in the third trimester because of the risks of macrosomia, placental insufficiency, and the need to make informed decisions about timing of delivery.

Standard monitoring for women with GDM from approximately 28 to 32 weeks onward includes:

Serial fetal growth scans: Ultrasound measurement of fetal abdominal circumference, head circumference, and estimated fetal weight every three to four weeks. Macrosomia (estimated fetal weight above the 90th centile) or large abdominal circumference relative to head circumference indicates excessive glucose exposure and prompts medication review.

Amniotic fluid assessment: Polyhydramnios (excess amniotic fluid) is associated with GDM and is monitored on serial ultrasounds.

Biophysical profile and non-stress test: Fetal wellbeing assessment, particularly in the final weeks of pregnancy or when there is concern about fetal growth restriction (a less common complication when GDM produces placental dysfunction rather than macrosomia).

Timing of delivery: Women with well-controlled GDM on diet alone with no complications typically deliver at 40 to 41 weeks. Women on insulin or with macrosomia, poor glucose control, or additional complications may be recommended elective delivery between 37 and 39 weeks to reduce the risk of shoulder dystocia and stillbirth.

After Delivery: What Happens to GDM

In most women, gestational diabetes resolves after delivery, when the placental hormones driving insulin resistance are no longer present. Blood glucose typically returns to normal within hours to days after birth.

However, GDM has important long-term implications:

  • Women with GDM have a 35 to 50% risk of developing type 2 diabetes within 5 to 10 years after delivery

  • Postpartum glucose testing at 6 to 12 weeks after delivery is recommended to confirm that blood sugar has returned to the normal range

  • Annual HbA1c or fasting glucose testing is recommended indefinitely for women with a history of GDM

  • Breastfeeding reduces the risk of both maternal type 2 diabetes and childhood metabolic syndrome in the baby

  • Lifestyle maintenance after delivery, including healthy diet and regular exercise, is the most effective intervention for reducing the long-term diabetes risk

Women who experienced GDM in one pregnancy carry a 40 to 69% risk of GDM recurrence in subsequent pregnancies. Preconception optimisation (achieving a healthy weight, controlling blood glucose before the next pregnancy) reduces this recurrence risk.

GDM Care at Humayun Hospital, T Nagar

At Humayun Hospital, T Nagar, Chennai, Dr. Asma Humayun provides specialist obstetric management for women with gestational diabetes, from screening and diagnosis through the complete management pathway to postnatal follow-up.

Dr. Asma Humayun is a Gynaecologist and Obstetrician with over 15 years of clinical experience, holding MBBS, DGO (Sri Ramachandra University), Fellowship in Assisted Reproductive Techniques (F.ART), Fellowship in Minimal Access Surgery (F.MAS), Diploma in Reproductive Medicine (Germany), and MRCOG (Royal College of Obstetricians and Gynaecologists, UK).

We offer:

  • OGTT screening at 24 to 28 weeks for all pregnant patients, with earlier screening for high-risk women

  • Clear explanation of diagnosis, targets, and management plan at the time of GDM diagnosis

  • Personalised medical nutrition therapy guidance adapted to the South Indian diet

  • Blood glucose monitoring instruction and target-setting

  • Insulin initiation and dose titration for women requiring pharmacological management

  • Metformin prescription and counselling for appropriate patients

  • Serial fetal growth scanning and biophysical profile monitoring from 28 weeks

  • Timing of delivery planning based on glucose control, fetal growth, and individual risk profile

  • Postpartum glucose testing at six weeks to confirm GDM resolution

  • Long-term diabetes risk counselling and annual review recommendation for women with GDM history

Gestational diabetes is not a failure. It is a metabolic challenge that pregnancy creates, and with the right management it does not have to compromise a healthy pregnancy or a healthy baby.

Chat with our medical assistant for quick guidance and support.

Frequently Asked Questions

Most women with gestational diabetes have no noticeable symptoms. When symptoms occur they may include increased thirst, more frequent urination, unusual fatigue, blurred vision, and increased hunger, but these overlap significantly with normal third-trimester experiences. The absence of symptoms does not exclude GDM. Diagnosis is made by the OGTT screening between 24 and 28 weeks, not by symptoms alone.

Source Links